RxDoctor Payments Data

Annu Goel, DPM

Podiatrist · Toledo, OHNPI 1639172661

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,123 of the $6,803 with a category attached, or 75.3%. It is spread thinly across 34 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,619 and has fallen 66.6% since, to $876 in 2025.

$6,803in general payments, 2019–2025

Across 189 payments — averaging $35.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$1K
  • CDC Medical LLC$872
  • Smith+Nephew$842
  • Amniox Medical, Inc.$818
  • Stryker$579
  • Abbott$480
  • plus $2K from 28 others

What the payments were for

  • Consulting fees$1512%
  • Travel & lodging$65710%
  • Food & beverage$5,12375%
  • Education$87213%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,803 in reported general payments places this provider in the 85th percentile of 397 podiatrist providers in Ohio.

See all podiatrist providers in Ohio

Medicare billing

Part B allowed, 2024
$107,883
Medicare patients
204
Services billed
1,386

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate37$365
CiclopiroxCiclopirox Olamine16$319
Terbinafine Hcl17$130
Allopurinol20$123
Silver Sulfadiazine19$79
Ciprofloxacin Hcl18$73
Pregabalin11$39

Paid to pharmacies, not to this prescriber.

Other podiatrist in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →